Funding for this research was provided by:
Jiangxi Provincial Department of Science and Technology (50000, 20161bg70078, 2016.9-2018.12)
Article History
Received: 11 October 2021
Accepted: 6 December 2021
First Online: 1 March 2022
Declarations
:
: No potential conflict of interest was reported by the authors.
: All authors have agreed to publish this manuscript in Inflammopharmacology.